Finance

Lists
Why is GYRE up 2,86%?
Dive Deeper
GYRE:NASDAQ
Gyre Therapeutics Inc
7,20 $
+2,86%
(+0,20) 1D
2 қаз., 12:52:48 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GYRE...
Open
7,09 $
High
7,35 $
Low
7,08 $
Mkt. cap
763,44 млн
Avg. vol.
150,78 м.
Volume
65,04 мың
52-wk high
9,42 $
52-wk low
5,44 $
EPS
-0,20 $
Beta
2,18
Shares outstanding
106,03 млн
No. of employees
625
Open
7,09 $
High
7,35 $
Low
7,08 $
Mkt. cap
763,44 млн
Avg. vol.
150,78 м.
Volume
65,04 мың
52-wk high
9,42 $
52-wk low
5,44 $
EPS
-0,20 $
Beta
2,18
Shares outstanding
106,03 млн
No. of employees
625
News stories
From web sources and news partners
About Gyre Therapeutics Inc
CEO-
Employees625
Founded1997
HeadquartersУинстон-Сейлем, Солтүстік Каролина, Америка Құрама Штаттары
Sector-
Websitegyretx.com
Analyst ratings
Based on 2 analysts giving stock ratings to GYRE in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for GYRE in the last 3 months.
Highest
Current 7,20 $
20,00 $ (+177,78%)
Average
19,00 $ (+163,89%)
Lowest
18,00 $ (+150,00%)
Analyst
Recommendation
Action
Price target
Projected
Date
Robert LeBoyer
Noble Financial
Buy
Reiterated
20,00 $
+177,8%
08/10/2026
Matthew Keller
H.C. Wainwright
Buy
Reiterated
18,00 $
+150%
08/07/2026
Roger Song
Jefferies
Buy
Initiated
16,00 $
+122,2%
10/10/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
30,56 млн
37,20 млн
24,43 млн
29,10 млн
Cost of goods sold
1,63 млн
1,74 млн
1,23 млн
2,21 млн
Cost of revenue
1,63 млн
1,74 млн
1,23 млн
2,21 млн
Research and development expenses
2,36 млн
4,82 млн
11,48 млн
19,14 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19,65 млн
30,52 млн
24,31 млн
21,62 млн
Operating expense
22,01 млн
35,33 млн
35,79 млн
40,76 млн
Total operating expenses
23,64 млн
37,08 млн
37,02 млн
42,97 млн
Operating income
6,93 млн
120,00 м.
-12,59 млн
-13,86 млн
Other non operating income
604,00 м.
-2,31 млн
244,00 м.
-811,00 м.
EBT including unusual items
7,63 млн
-66,00 мың
-18,03 млн
-14,43 млн
EBT excluding unusual items
7,63 млн
-864,00 м.
-11,65 млн
-13,93 млн
Income tax expense
1,69 млн
1,30 млн
549,00 м.
-164,00 м.
Effective tax rate
22,19%
-1 969,70%
-3,04%
1,14%
Other operating expenses
-
-
-
-
Net income
3,61 млн
-1,72 млн
-10,30 млн
-10,60 млн
Net profit margin
11,81%
-4,63%
-42,16%
-36,44%
Earnings per share
0,03
0,05
-
-
Interest and investment income
100,00 м.
1,35 млн
743,00 м.
740,00 м.
Interest expense
-
-
-
-
Net interest expenses
100,00 м.
1,35 млн
743,00 м.
740,00 м.
Depreciation and amortization charges
-
-
-
-
EBITDA
7,58 млн
815,00 м.
-11,92 млн
-12,38 млн
Gain or loss from assets sale
1,00 мың
2,00 мың
16,00 мың
2,00 мың
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google қолданбалары